Products > IHC > Antibodies for immunohistochemistry

Antibodies for immunohistochemistry

Reach out to the antigen

In addition to the well-known own brand Zytomed Systems, the current program includes tried and tested reagents from Diagnostic Biosystems, BioCare Medical, Zeta Corporation among others. We are constantly testing new antibodies and detection systems to meet the specific requirements of the laboratories and scientific users in the best possible way. Most of the primary antibodies are available both as concentrates and as ready-to-use products.

Sorry, no results could be found for your request.

Products may not be approved or available in your region. Please check with your local Zytomed-Systems representative.

Product

Clone

Order no.

Host	Mouse
Clone	D2-40
Format	Ready-to-use
Reactivity	-
Method	P
Positive control	Germ cell tumor.
Dilution	-
Isotype	IgG1 /κ
Immunogen	M2A
Localization	Cytoplasm

Podoplanin

D2-40

Z2097MP

Host	Mouse
Clone	D2-40
Format	Concentrate
Reactivity	-
Method	P
Positive control	Germ cell tumor.
Dilution	1:20 - 1:100
Isotype	IgG1 /κ
Immunogen	M2A
Localization	Cytoplasm

Podoplanin

D2-40

Z2097MS

Host	Mouse
Clone	D2-40
Format	Concentrate
Reactivity	-
Method	P
Positive control	Germ cell tumor.
Dilution	1:20 - 1:100
Isotype	IgG1 /κ
Immunogen	M2A
Localization	Cytoplasm

Podoplanin

D2-40

Z2097MT

Host	Mouse
Clone	D2-40
Format	Ready-to-use
Method	P
Pretreatment	EDTA
Positive control	Lymphendothelium
Dilution	-
Isotype	Mouse IgG1
Localization	Cytoplasm

Podoplanin (Lymphatic endothelium marker)

D2-40

PDM558

Host	Mouse
Clone	D2-40
Format	Ready-to-use
Method	P
Pretreatment	EDTA
Positive control	Lymphendothelium
Dilution	-
Isotype	Mouse IgG1
Localization	Cytoplasm

Podoplanin (Lymphatic endothelium marker)

D2-40

PDM558-25

Host	Monospecific Mouse
Clone	ZM31
Format	Concentrate
Reactivity	-
Method	P
Pretreatment	Citrate or EDTA
Positive control	Mesothelioma.
Dilution	1:100 - 1:200
Isotype	IgG1 /κ
Immunogen	Recombinant human Podoplanin (PDPN) protein fragment (around aa 24-126)
Localization	Cytoplasm

Podoplanin (Lymphatic endothelium marker)

ZM31

Z2338ML

Host	Monospecific Mouse
Clone	ZM31
Format	Ready-to-use
Reactivity	-
Method	P
Pretreatment	Citrate or EDTA
Positive control	Mesothelioma.
Dilution	-
Isotype	IgG1 /κ
Immunogen	Recombinant human Podoplanin (PDPN) protein fragment (around aa 24-126)
Localization	Cytoplasm

Podoplanin (Lymphatic endothelium marker)

ZM31

Z2338MP

Host	Monospecific Mouse
Clone	ZM31
Format	Concentrate
Reactivity	-
Method	P
Pretreatment	Citrate or EDTA
Positive control	Mesothelioma.
Dilution	1:100 - 1:200
Isotype	IgG1 /κ
Immunogen	Recombinant human Podoplanin (PDPN) protein fragment (around aa 24-126)
Localization	Cytoplasm

Podoplanin (Lymphatic endothelium marker)

ZM31

Z2338MS

Host	Monospecific Mouse
Clone	ZM31
Format	Concentrate
Reactivity	-
Method	P
Pretreatment	Citrate or EDTA
Positive control	Mesothelioma.
Dilution	1:100 - 1:200
Isotype	IgG1 /κ
Immunogen	Recombinant human Podoplanin (PDPN) protein fragment (around aa 24-126)
Localization	Cytoplasm

Podoplanin (Lymphatic endothelium marker)

ZM31

Z2338MT

Host	Rabbit
Clone	EPR20330
Format	Concentrate
Method	P
Pretreatment	EDTA
Positive control	Melanoma, testis
Dilution	1:100
Isotype	IgG
Immunogen	Recombinant fragment within Human PRAME aa 100 to the C-terminus. The exact sequence is proprietary.
Localization	Nucleus, cell membrane

PRAME

EPR20330

ACI3252A

Host	Rabbit
Clone	EPR20330
Format	Concentrate
Method	P
Pretreatment	EDTA
Positive control	Melanoma, testis
Dilution	1:100
Isotype	IgG
Immunogen	Recombinant fragment within Human PRAME aa 100 to the C-terminus. The exact sequence is proprietary.
Localization	Nucleus, cell membrane

PRAME

EPR20330

ACI3252B

Host	Rabbit
Clone	EPR20330
Format	Ready-to-use
Method	P
Pretreatment	EDTA
Positive control	Melanoma
Dilution	-
Isotype	IgG
Immunogen	Recombinant fragment within Human PRAME aa 100 to the C-terminus. The exact sequence is proprietary.
Localization	Nucleus, cell membrane

PRAME

EPR20330

ALI3252G7

Host	Rabbit
Clone	EPR20330
Format	Ready-to-use
Method	P
Pretreatment	EDTA
Positive control	Melanoma
Dilution	-
Isotype	IgG
Immunogen	Recombinant fragment within Human PRAME aa 100 to the C-terminus. The exact sequence is proprietary.
Localization	Nucleus, cell membrane

PRAME

EPR20330

API3252AA

Host	Rabbit
Clone	EPR20330
Format	ready-to-use
Method	P
Pretreatment	EDTA
Positive control	Melanoma
Dilution	-
Isotype	Rabbit IgG
Localization	Nucleus, Cytoplasma membrane

PRAME

EPR20330

RBG073

Host	Rabbit
Clone	EPR20330
Format	Concentrate
Method	P
Pretreatment	EDTA
Positive control	Melanoma
Dilution	1:50 - 1:100
Isotype	Rabbit IgG
Localization	Nucleus, Cytoplasma membrane

PRAME

EPR20330

RBK073-05

Host	Rabbit
Clone	EPR20330
Format	Concentrate
Method	P
Pretreatment	EDTA
Positive control	Melanoma
Dilution	1:50 - 1:100
Isotype	IgG
Immunogen	Recombinant fragment within Human PRAME aa 100 to the C-terminus. The exact sequence is proprietary.
Localization	Nucleus, cell membrane

PRAME

EPR20330

RMAB109

Host	Rabbit
Clone	EPR20330
Format	Concentrate
Method	P
Pretreatment	EDTA
Positive control	Melanoma
Dilution	1:50 - 1:100
Isotype	IgG
Immunogen	Recombinant fragment within Human PRAME aa 100 to the C-terminus. The exact sequence is proprietary.
Localization	Nucleus, cell membrane

PRAME

EPR20330

RMAB109-01

Host	Rabbit
Clone	EPR20330
Format	Concentrate
Method	P
Pretreatment	EDTA
Positive control	Melanoma
Dilution	1:50 - 1:100
Isotype	IgG
Immunogen	Recombinant fragment within Human PRAME aa 100 to the C-terminus. The exact sequence is proprietary.
Localization	Nucleus, cell membrane

PRAME

EPR20330

RMAB109-05

Host	Rabbit
Clone	EPR20330
Format	Ready-to-use
Method	P
Pretreatment	EDTA
Positive control	Melanoma
Dilution	-
Isotype	IgG
Immunogen	Recombinant fragment within Human PRAME aa 100 to the C-terminus. The exact sequence is proprietary.
Localization	Nucleus, cell membrane

PRAME

EPR20330

RMPD109

Host	Mouse
Clone	2G11
Format	Purified
Method	EL, P
Pretreatment	Citrate
Isotype	Mouse IgG2a
Immunogen	Synthetic peptide 146-R (154) R (171) -182 of ovine PrP

Prion Protein (PrP, CD230)

2G11

616-0195

Host	Rabbit
Clone	SP2
Format	Concentrate
Method	F, P
Pretreatment	EDTA pH8
Positive control	Breast Carcinoma
Dilution	1:25 -1:50
Isotype	Rabbit IgG
Localization	Nucleus

Progesterone Receptor

SP2

RMAB002

Host	Rabbit
Clone	SP2
Format	Concentrate
Method	F, P
Pretreatment	EDTA pH8
Positive control	Breast Carcinoma
Dilution	1:25 - 1:50
Isotype	Rabbit IgG
Localization	Nucleus

Progesterone Receptor

SP2

RMAB002-01

Host	Rabbit
Clone	SP2
Format	Concentrate
Method	F, P
Pretreatment	EDTA pH8
Positive control	Breast Carcinoma
Dilution	1:25 - 1:50
Isotype	Rabbit IgG
Localization	Nucleus

Progesterone Receptor

SP2

RMAB002-05

Host	Rabbit
Clone	SP2
Format	Ready-to-use
Method	F, P
Pretreatment	EDTA pH8
Positive control	Breast Carcinoma
Dilution	-
Isotype	Rabbit IgG
Localization	Nucleus

Progesterone Receptor

SP2

RMPD002

Host	Rabbit
Clone	ZR4
Format	Concentrate
Reactivity	-
Method	P
Positive control	Breast carcinomas.
Dilution	1:200 - 1:400
Isotype	IgG
Immunogen	Recombinant protein encoding human progesterone receptor 412-526 aa
Localization	Nucleus

Progesterone Receptor

ZR4

Z2023RL

Host	Rabbit
Clone	ZR4
Format	Ready-to-use
Reactivity	-
Method	P
Positive control	Breast carcinomas.
Dilution	-
Isotype	IgG
Immunogen	Recombinant protein encoding human progesterone receptor 412-526 aa
Localization	Nucleus

Progesterone Receptor

ZR4

Z2023RP

Host	Rabbit
Clone	ZR4
Format	Concentrate
Reactivity	-
Method	P
Positive control	Breast carcinomas.
Dilution	1:200 - 1:400
Isotype	IgG
Immunogen	Recombinant protein encoding human progesterone receptor 412-526 aa
Localization	Nucleus

Progesterone Receptor

ZR4

Z2023RS

Host	Rabbit
Clone	ZR4
Format	Concentrate
Reactivity	-
Method	P
Positive control	Breast carcinomas.
Dilution	1:200 - 1:400
Isotype	IgG
Immunogen	Recombinant protein encoding human progesterone receptor 412-526 aa
Localization	Nucleus

Progesterone Receptor

ZR4

Z2023RT

Host	Rabbit
Clone	ZR290
Format	Concentrate
Reactivity	-
Method	P
Positive control	Breast carcinomas.
Dilution	1:100 - 1:200
Isotype	IgG
Immunogen	Recombinant fragment (around aa 1-200) of human PGR
Localization	Nucleus

Progesterone Receptor

ZR290

Z2728RL

Host	Rabbit
Clone	ZR290
Format	r-t-u
Reactivity	-
Method	P
Positive control	Breast carcinomas.
Dilution	gebrauchsfertig
Isotype	IgG
Immunogen	Recombinant fragment (around aa 1-200) of human PGR
Localization	Nucleus

Progesterone Receptor

ZR290

Z2728RP

Host	Rabbit
Clone	ZR290
Format	Concentrate
Reactivity	-
Method	P
Positive control	Breast carcinomas.
Dilution	1:100 - 1:200
Isotype	IgG
Immunogen	Recombinant fragment (around aa 1-200) of human PGR
Localization	Nucleus

Progesterone Receptor

ZR290

Z2728RS

Host	Rabbit
Clone	ZR290
Format	Concentrate
Reactivity	-
Method	P
Positive control	Breast carcinomas.
Dilution	1:100 - 1:200
Isotype	IgG
Immunogen	Recombinant fragment (around aa 1-200) of human PGR
Localization	Nucleus

Progesterone Receptor

ZR290

Z2728RT

Host	Mouse
Clone	ZM203
Format	Concentrate
Reactivity	-
Method	P
Positive control	Pituitary gland.
Dilution	1:100 - 1:200
Isotype	IgG1 /κ
Immunogen	Recombinant fragment of human Prolactin (PRL) protein (around aa 63-201)
Localization	Cytoplasm

Prolactin

ZM203

Z2523ML

Host	Mouse
Clone	ZM203
Format	Ready-to-use
Reactivity	-
Method	P
Positive control	Pituitary gland.
Dilution	-
Isotype	IgG1 /κ
Immunogen	Recombinant fragment of human Prolactin (PRL) protein (around aa 63-201)
Localization	Cytoplasm

Prolactin

ZM203

Z2523MP

Host	Mouse
Clone	ZM203
Format	Concentrate
Reactivity	-
Method	P
Positive control	Pituitary gland.
Dilution	1:100 - 1:200
Isotype	IgG1 /κ
Immunogen	Recombinant fragment of human Prolactin (PRL) protein (around aa 63-201)
Localization	Cytoplasm

Prolactin

ZM203

Z2523MS

Host	Mouse
Clone	ZM203
Format	Concentrate
Reactivity	-
Method	P
Positive control	Pituitary gland.
Dilution	1:100 - 1:200
Isotype	IgG1 /κ
Immunogen	Recombinant fragment of human Prolactin (PRL) protein (around aa 63-201)
Localization	Cytoplasm

Prolactin

ZM203

Z2523MT

Host	Rabbit
Clone	polyclonal
Format	Concentrate
Method	P
Pretreatment	Citrate
Positive control	Pituitary Gland
Dilution	1:200
Isotype	Rabbit Ig
Immunogen	Purified human prolactin
Localization	Cytoplasm

Prolactin (LTH, Luteotropic Hormone, Lactogenic Hormone)

polyclonal

516-17492

Host	Rabbit
Clone	polyclonal
Format	Concentrate
Method	P
Pretreatment	Citrate
Positive control	Pituitary Gland
Dilution	1:200
Isotype	Rabbit Ig
Immunogen	Purified human prolactin
Localization	Cytoplasm

Prolactin (LTH, Luteotropic Hormone, Lactogenic Hormone)

polyclonal

516-17494

Host	Mouse
Clone	XM26+LL002+4A4
Format	Ready-to-use
Method	P
Pretreatment	ULTRA CC1
Positive control	Normal prostate
Dilution	-
Isotype	Mouse IgG1+IgG3+IgG 2a/kappa
Localization	Cytoplasm and nucleus

Prostate Cocktail, 2X (CK5+CK14+p63)

XM26+LL002+4A4

AVI3206G

Host	Rabbit
Clone	ZR9
Format	Concentrate
Reactivity	-
Method	P
Positive control	Normal prostate or prostate carcinoma.
Dilution	1:200
Isotype	IgG
Immunogen	Synthesized peptides to the N-terminus of human protein
Localization	Cytoplasm

Prostein (P501S)

ZR9

Z2006RL

Host	Rabbit
Clone	ZR9
Format	Ready-to-use
Reactivity	-
Method	P
Positive control	Normal prostate or prostate carcinoma.
Dilution	-
Isotype	IgG
Immunogen	Synthesized peptides to the N-terminus of human protein
Localization	Cytoplasm

Prostein (P501S)

ZR9

Z2006RP

Host	Rabbit
Clone	ZR9
Format	Concentrate
Reactivity	-
Method	P
Positive control	Normal prostate or prostate carcinoma.
Dilution	1:200
Isotype	IgG
Immunogen	Synthesized peptides to the N-terminus of human protein
Localization	Cytoplasm

Prostein (P501S)

ZR9

Z2006RS

Host	Rabbit
Clone	ZR9
Format	Concentrate
Reactivity	-
Method	P
Positive control	Normal prostate or prostate carcinoma.
Dilution	1:200
Isotype	IgG
Immunogen	Synthesized peptides to the N-terminus of human protein
Localization	Cytoplasm

Prostein (P501S)

ZR9

Z2006RT

Host	Mouse
Clone	31A3
Format	Purified
Method	P, WB, EL
Pretreatment	Citrate
Dilution	1:100 - 1:400 (P)
Isotype	Mouse IgG1
Immunogen	Native from brain